Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ALDH1A1 is a cytosolic enzyme that catalyzes the NAD(P)+–dependent oxidation of aldehydes, playing a role in detoxification and cellular metabolism. It is primarily known for oxidizing retinaldehyde to retinoic acid, regulating gene transcription involved in cell proliferation, differentiation, and development. It is also a cancer stem cell marker and contributes to chemoresistance.
Enzyme inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aldehyde dehydrogenase 1 family member A1 (ALDH1A1).